Cardiovascular Disease in Anti-neutrophil Cytoplasm Antibody-Associated Vasculitis

M Sayer, GB Chapman, M Thomas… - Current rheumatology …, 2024 - Springer
Abstract Purpose of Review Anti-neutrophil cytoplasm antibody (ANCA)-associated
vasculitis (AAV) is a rare, multisystem, autoimmune disease characterised by microvascular …

Cardiovascular and cerebrovascular outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis: A systematic review with meta-analysis

W Xie, S Xiao, X Li, J Huang, Z Zhang - Autoimmunity Reviews, 2024 - Elsevier
Objective To quantify the magnitude of the risk of total and type-specific cardiovascular and
cerebrovascular diseases (CCVD) in patients with anti-neutrophil cytoplasmic antibody …

Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies

E Houben, EL Penne, AE Voskuyl… - …, 2018 - academic.oup.com
Objectives Several chronic inflammatory diseases are associated with cardiovascular
disease, but the risk in ANCA-associated vasculitis is poorly quantified. The aim of the …

Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes

L Shi - Rheumatology International, 2017 - Springer
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a primary small-vessel
vasculitis group with three distinct clinical entities, including GPA, MPA, and EGPA. The …

[HTML][HTML] Recent advancements in the management of anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic review

H Arzoun, M Srinivasan, SR Thangaraj, SS Thomas… - Cureus, 2022 - ncbi.nlm.nih.gov
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a rare multisystem
autoimmune condition that causes inflammation of small and medium-sized blood vessels …

New Therapeutic Targets in Antineutrophil Cytoplasm Antibody–Associated Vasculitis

M Prendecki, SP McAdoo - Arthritis & Rheumatology, 2021 - Wiley Online Library
Antineutrophil cytoplasm antibody (ANCA)–associated vasculitis (AAV) is a rare systemic
autoimmune disease that is characterized by necrotizing inflammation of predominantly the …

Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?

L Floyd, AD Morris, A Woywodt… - Clinical Kidney …, 2022 - academic.oup.com
The association between cardiovascular (CV) disease and anti-neutrophil cytoplasmic
antibody (ANCA)-associated vasculitis (AAV) is well documented. The recent work by …

Management of cardiovascular risk factors in patients with ANCA‐associated vasculitis

CP Bramlage, J Kröplin, M Wallbach… - Journal of Evaluation …, 2017 - Wiley Online Library
Objectives Anti‐neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) is
accompanied by increased cardiovascular (CV) risk. Treatment of AAV patients includes the …

Outcome measures for antineutrophil cytoplasmic antibody-associated vasculitis

G Tomasson - Current Opinion in Rheumatology, 2015 - journals.lww.com
Outcome measures for antineutrophil cytoplasmic antibody-ass... : Current Opinion in
Rheumatology Outcome measures for antineutrophil cytoplasmic antibody-associated vasculitis …

[HTML][HTML] The pathogenesis and treatment in antineutrophil cytoplasmic antibody associated vasculitis

SS Li, SL Wang, HJ Zhang, SH He… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a systemic
autoimmune disease characterized by leukocytoclastic inflammation of small blood vessels …